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Yasukochi Y, Sakuma J, Takeuchi I, Kato K, Oguri M, Fuji-
maki T, Horibe H, Yamada Y. Identification of three genetic
variants as novel susceptibility loci for body mass index in a Japanese
population. Physiol Genomics 50: 179–189, 2018. First published
January 12, 2018; doi:10.1152/physiolgenomics.00117.2017.—Re-
cent genome-wide association studies have identified various obesity
or metabolic syndrome (MetS) susceptibility loci. However, most
studies were conducted in a cross-sectional manner. To address this
gap, we performed a longitudinal exome-wide association study to
identify susceptibility loci for obesity and MetS in a Japanese popu-
lation. We traced clinical data of 6,022 Japanese subjects who had
annual health check-ups for several years (mean follow-up period, 5
yr) and genotyped ~244,000 genetic variants. The association of
single nucleotide polymorphisms (SNPs) with body mass index (BMI)
or the prevalence of obesity and MetS was examined in a generalized
estimating equation model. Our longitudinal exome-wide association
studies detected 21 BMI- and five MetS-associated SNPs (false
discovery rate, FDR 0.01). Among these SNPs, 16 have not been
previously implicated as determinants of BMI or MetS. Cross-sec-
tional data for obesity- and MetS-related phenotypes in 7,285 Japa-
nese subjects were examined in a replication study. Among the 16
SNPs, three (rs9491140, rs145848316, and rs7863248) were related to
BMI in the replication cohort (P  0.05). In conclusion, three SNPs
[rs9491140 of NKAIN2 (FDR  0.003, P  1.9  105),
rs145848316 of KMT2C (FDR  0.007, P  4.5  105), and
rs7863248 of AGTPBP1 (FDR  0.006, P  4.2  105)] were
newly identified as susceptibility loci for BMI.
body mass index; exome-wide association study; longitudinal data;
metabolic syndrome; obesity
INTRODUCTION
Obesity is a serious worldwide health problem because it can
lead to an increased risk of adverse outcomes in cardiovascular
diseases such as coronary artery disease and stroke (38). In
Japan, it is widely accepted that an individual with a body mass
index (BMI) of 25 kg/m2 is classified as obese (16). In
previous decades, genome-wide association studies (GWASs)
have identified over 100 loci or genes that confer susceptibility
to obesity-related traits (1, 11, 13, 33). Single nucleotide
polymorphisms (SNPs) of the identified genes such as FTO
showed significant association with obesity-related traits across
diverse ethnic populations (13, 24, 26). In contrast, some
GWASs have identified ethnic-specific (20, 21) or sex-specific
SNPs (40) associated with obesity.
Metabolic syndrome (MetS) is also a serious health problem
and increases the risk of cardiovascular diseases, diabetes
mellitus (17), and cancer (12). Generally, a minimum of three
metabolic abnormalities would be required to diagnose an
individual with MetS (17). Recent GWASs have identified
genetic variants related to the clinical manifestations of MetS,
and genetic association studies for MetS-related phenotypes
have previously been reviewed elsewhere (2, 28). Similar to
GWASs for obesity-related phenotypes, common MetS-asso-
ciated genetic variants across several ethnic groups have been
identified (46); however, interethnic differences in MetS sus-
ceptibility loci were also observed (3, 23).
It is possible that interethnic variability is due to differences
in genetic background among ethnic groups, sample sizes, or
statistical methods used. Therefore, novel genetic variants
associated with obesity- or MetS-related traits in a Japanese
population remain to be identified definitively. Despite identi-
fying various susceptibility loci for obesity and MetS, most
GWASs have been conducted in a cross-sectional manner that
commonly measures traits at a single point in time. Previous
studies have shown that compared with cross-sectional data,
longitudinal data provide a potential power gain to detect
association in GWASs (35, 44). Thus, we have examined
anthropometric and clinical data in 6,026 Japanese individuals
who had annual health check-ups for several years, and per-
formed a longitudinal exome-wide association study to identify
novel susceptibility loci for obesity or MetS.
METHODS
Compliance with ethical standards. The study protocol complied
with the Declaration of Helsinki and was approved by the Committees
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on the Ethics of Human Research of Mie University Graduate School
of Medicine and Inabe General Hospital. Written informed consent
was obtained from all subjects before enrollment in the study.
Study subjects. A total of 6,026 community-dwelling individuals
were recruited from those who visited the Health Care Center of Inabe
General Hospital (Inabe, Mie, Japan) for an annual health check-up
from April 2003 to March 2014. All participants had each undergone
1–11 medical examinations (a total of 28,529 examinations), and the
average follow-up period was 5 yr. We refer to this cohort as the
“discovery cohort.” Methods for the collection and storage of medical
examination data and genomic DNA samples have been described
previously (45). Cross-sectional data for obesity- and MetS-related
traits in 7,285 Japanese subjects (Gifu Prefectural Tajimi Hospital,
Tajimi; Gifu Prefectural General Medical Center, Gifu; Japanese Red
Cross Nagoya First Hospital, Nagoya; Hirosaki University Hospital
and Hirosaki Stroke Center, Hirosaki, Japan) were used for replication
studies of candidate SNPs identified in our longitudinal exome-wide
association studies. We refer to this cohort as the “replication cohort.”
Obesity was defined as having a BMI of 25 kg/m2, and individ-
uals with a BMI of25 kg/m2 were regarded as controls, based on the
criteria of obesity for Japanese and Asians (16). According to this
definition, the discovery cohort consisted of 1,804 subjects with
obesity and 4,222 controls. MetS was diagnosed according to the
definition proposed by six organizations (17). In the discovery cohort,
a total of 1,577 subjects were defined as having MetS because the
subjects had three or more of the following components: 1) a waist
circumference of 90 cm for men or 80 cm for women; 2) a serum
triglyceride concentration of 1.65 mmol/l (150 mg/dl) or drug
treatment for elevated triglycerides; 3) a serum high-density lipopro-
tein (HDL)-cholesterol concentration of 1.04 mmol/l (40 mg/dl) for
men or 1.30 mmol/l (50 mg/dl) for women; 4) a systolic blood
pressure of 130 mmHg, diastolic blood pressure of 85 mmHg, or
drug treatment for hypertension; and 5) a fasting plasma glucose level
of 5.50 mmol/l (100 mg/dl) or drug treatment for elevated glucose.
The control subjects comprised 1,848 individuals who had none of the
five components of MetS. Status of obesity or MetS was based on
medical examination data in the final visit for each subject. The
definition of other complex disorders (hypertension, Type 2 diabetes
mellitus, dyslipidemia, chronic kidney disease, and hyperuricemia)
was described previously (25). In the replication study, cross-sectional
data for 2,150 subjects with obesity and 4,792 controls or for 968
subjects with MetS and 2,421 controls were examined.
Longitudinal exome-wide association study. We performed longi-
tudinal exome-wide association studies for obesity- and MetS-related
phenotypes, based on genotyping data and longitudinal data of med-
ical examinations from all subjects in the discovery cohort. Infinium
HumanExome-12 ver. 1.2 BeadChip and Infinium Exome-24 ver 1.0
BeadChip (Illumina, San Diego, CA) were used for genotyping. These
exome arrays include ~244,000 putative functional exonic variants
selected from 12,000 individual exome and whole-genome se-
quences across diverse ethnic populations (14). The exome-wide
association study is a focused genotyping method and differs from
GWAS, which includes up to 4.5 million markers for genetic variants
throughout the entire genome. Following the genotyping of 6,026
subjects in the discovery cohort, we performed quality controls for the
genotyping data. First, monomorphic sites among the subjects were
discarded. Second, we removed genetic variants with a call rate of
97.0% or a minor allele frequency (MAF) of 0.05, or those whose
genotype distribution significantly deviated from the Hardy-Weinberg
equilibrium (P  0.001) in controls. Analysis of the association of
genetic variants on sex chromosomes with phenotypes is complicated
because of the difference in the copy number between men and
women and of X-inactivation in women. Genetic variants located on
sex chromosomes were thus discarded. Genetic variants in the mito-
chondrial DNA were also removed. After the quality control, a total of
24,579 SNPs were selected and subjected to further analyses. A
principal component analysis (PCA) of SNPs using the EIGEN-
STRAT method (29) was conducted with JMP Genomics version 6.0
(SAS Institute, Cary, NC) to detect population stratification. The PCA
detected four population outliers, and they were removed from further
analyses.
Next, we converted the genotyping data of 6,022 subjects in the
discovery cohort into numeric data with dominant, recessive, and
additive models. The dominant and recessive models were defined as
“0, AA; 1, AB  BB” and “0, AA  AB; 1, BB” (A, major allele; B,
minor allele), respectively, whereas the additive model was defined as
“0, AA; 1, AB; 2, BB.”
Statistical analyses. Using the SNPs and clinical data sets from
6,022 subjects in the discovery cohort, we assessed the association of
SNPs with the prevalence of obesity and MetS, or BMI by the
generalized estimating equation (GEE) model (18) with adjustments
for age and sex by the use of the R package “geepack” (15) through
RStudio version 1.0.136 (32). The waves argument was used to
specify the ordering of repeated measurements within individuals. In
the discovery cohort, distributions of BMI were different between
men and women (Fig. 1). Therefore, the GEE model with adjustment
for age was independently applied to test association of SNPs with the
following categories: 1) BMI in all individuals, 2) BMI in men, and 3)
BMI in women. Quantile-quantile plots for the P values in the three
inheritance models are shown in Figs. 2, 3, 4.
Effects of many SNPs in exome arrays on obesity or MetS are not
independent because of linkage disequilibrium (LD) among SNPs.
Therefore, we calculated the false discovery rate (FDR) using the
Benjamin and Hochberg method (7) to compensate for multiple
comparison of genotypes with the phenotypes. An FDR of 0.01 was
considered statistical significance of association. Sitlani et al. (35)
reported that a small effective sample size can increase the chances of
generating type I errors, and they recommended the use of “approxdf,” a
scale of small effective sample size: approxdf  2  MAF  Nindep,
where Nindep is the sum of the estimated number of independent
observations per person. Thus, we estimated the approxdf by the R
package “bosswithdf” (35, 39), and discarded SNPs with an approxdf of
10. The association of candidate SNPs identified in our longitudinal
exome-wide association studies was tested in the replication cohort with
Fisher’s exact test for categorical data or linear regression analysis for
quantitative data.
Estimates of LD. We estimated the LD among SNPs using R
package “genetics” (42). Additionally, allele frequencies of target
SNPs within four ethnic groups (East Asian, South Asian, European,
and African populations) were examined based on information from
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Fig. 1. Count distribution for longitudinal data of body mass index (BMI) in
men (black) and BMI in women (gray) in the discovery cohort.
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the 1000 Genomes Project database (36) (http://www.international-
genome.org/).
RESULTS
Subject characteristics. Longitudinal characteristics of the
6,022 subjects in the discovery cohort are shown in Table 1.
The prevalence of obesity and MetS was higher in males than
in females; males accounted for 53.3% subjects with obesity
and 63.4% of subjects with MetS. The prevalence of hyper-
tension, Type 2 diabetes mellitus, dyslipidemia, chronic kidney
disease, and hyperuricemia was higher in patients with obesity
or MetS than that in their controls (Table 1). Most anthropo-
metric and clinical parameters (height, weight, waist circum-
ference, BMI, systolic and diastolic blood pressure, fasting
plasma glucose level, blood hemoglobin A1c content, and
serum concentrations of triglycerides, low density lipoprotein-
cholesterol, and uric acid) were greater, whereas serum con-
centration of HDL-cholesterol and estimated glomerular filtra-
tion rate were lower in subjects with obesity or MetS than in
corresponding controls.
Longitudinal exome-wide association study for the preva-
lence of obesity. The GEE model, with age and sex adjust-
ments, was used to test the association of 24,579 SNPs for the
three inheritance models with the prevalence of obesity in
6,022 subjects in the discovery cohort (Table 2). However,
there was no statistical significance between the prevalence of
obesity and SNPs in all inheritance models (FDR 0.01).
Longitudinal exome-wide association study for the preva-
lence of MetS. In our longitudinal exome-wide association
studies, the prevalence of MetS was significantly associated
with five SNPs in the three inheritance models (Table 2), and
their approxdf values were 10. Of these SNPs, three
(rs1052067 of PMF1, rs2305830 of CEP164, and rs4141253 of
RPH3A) have not been shown to be associated with the
prevalence of MetS, according to the DisGeNET [http://
www.disgenet.org/web/DisGeNET/ (27)], GWAS Catalog
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Fig. 2. Quantile-quantile plots for P values in the longitu-
dinal exome-wide association studies for the prevalence of
obesity and metabolic syndrome, and for BMI in the dom-
inant model. The observed P values (y-axis) were compared
with the expected P values (x-axis) under the null hypoth-
esis, with the values being plotted as –log10(P). BMI, body
mass index.  represents the genomic inflation factor.
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[https://www.ebi.ac.uk/gwas/ (22)], and GWAS Central
[https://www.gwascentral.org/ (6)] databases. We previously
showed that rs964184 of ZPR1 located in the same chromo-
somal region of CEP164 (11q23.3) was associated with MetS
in a Japanese population (37). According to a gene-disease
association score calculated by the number of sources reporting
the association in the DisGeNET database, the score of
rs964184 was the highest among SNPs associated with MetS
on chromosome 11. rs964184 of ZPR1 was not in LD with
rs2305830 of CEP164 detected in our longitudinal exome-wide
association studies (D=  0.075, r2  0.0008). The prevalence
of MetS increased in subjects with the minor allele of
rs2305830 or in those with the major allele of rs1052067 or
rs4141253 (FDR  0.003–0.007, Table 2 and Supplemental
Table S1), suggesting that these alleles of the SNPs are risk
factors for MetS. (The online version of this article contains
supplemental material.)
Based on the longitudinal data of discovery cohort, we
examined relationships between all five identified SNPs and
components of MetS in 3,424 subjects using the GEE model
for the additive model (Table 3). The rs2075290 of ZPR1 and
rs2266788 of APOA5, which were previously identified as
susceptibility loci for MetS-related phenotypes (13, 28, 37),
were significantly associated with serum concentrations of
triglycerides [P  0.0013 (0.05/40)]. In addition, three SNPs
(rs2075290, rs2266788, and rs2305830) and two SNPs
(rs2075290 and rs2266788) were significantly associated with
serum concentrations of HDL-cholesterol for men and women,
respectively.
Based on medical examination data in the final visit for each
subject in the discovery cohort, we tested the relationship
between allele frequencies of three newly identified SNPs and
the prevalence of MetS and calculated the odds ratios by the
Fisher’s exact test. Consequently, rs2305830 and rs4141253
were significantly [P  0.017 (0.05/3)] associated with the
prevalence of MetS; the odds ratios of the former and the latter
were 1.21 and 1.18, respectively. The association of rs1052067
with the prevalence of MetS was not statistically significant
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Fig. 3. Quantile-quantile plots for P values in the longitu-
dinal exome-wide association studies for the prevalence of
obesity and metabolic syndrome, and for BMI in the addi-
tive model. The observed P values (y-axis) were compared
with the expected P values (x-axis) under the null hypoth-
esis, with the values being plotted as –log10(P). BMI, body
mass index.  represents the genomic inflation factor.
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(P 0.10; odds ratio, 1.10). The association of rs1052067 was
only detected using the longitudinal MetS data in the GEE
model, indicating the increased statistical power of longitudi-
nal exome-wide association study compared with the corre-
sponding cross-sectional analysis.
Longitudinal exome-wide association study for BMI. The
GEE model showed that three and 11 SNPs were signifi-
cantly (FDR 0.01) associated with BMI measured from
6,022 subjects in the discovery cohort in the dominant and
additive models, respectively (Table 2). Of these SNPs, four
(rs1134767 of PATJ, rs41532447 of LOC105374511, and
rs2767434 and rs2254419 of CFAP46) have not been shown
to be associated with BMI. The minor allele of rs41532447
and major alleles of the remaining three SNPs were signif-
icantly associated with increased mean BMI values
(FDR  0.0019 – 0.0099, Table 2 and Supplemental Table
S1). This result suggests that these alleles are risk factors for
an increase in BMI. Eight SNPs at chromosomal region
1q25 and FTO were also significantly associated with BMI.
These SNPs were previously identified as susceptibility loci
for BMI and obesity (4, 8, 20, 41, 43). BMI values were
greater in individuals with the minor alleles of the eight
SNPs than in those with the major alleles, suggesting the
minor alleles representing risk factors for an increase in
BMI. The two SNPs at 1q25 (D=  0.996, r2  0.985) or six
SNPs in FTO (D=  0.995–1.000, r2  0.785– 0.999) were
in LD.
We detected significant association of BMI in 2,674 male
subjects with four SNPs in the three inheritance models (Table
2). The four SNPs (rs7656604 at 4q13.3, rs9491140 of
NKAIN2, rs2222328 of SCHIP1, and rs145848316 of KMT2C)
were newly identified in the present study. The GEE test
indicated that the minor alleles of rs7656604 and rs2222328
and major alleles of the other SNPs were associated with
increased BMI (FDR  0.0009–0.0069, Table 2 and Supple-
mental Table S1). The frequency of the major allele at
rs7656604 is increased in non-African populations (Supple-
mental Table S2).
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Fig. 4. Quantile-quantile plots for P values in the longitu-
dinal exome-wide association studies for the prevalence of
obesity and metabolic syndrome, and for BMI in the
recessive model. The observed P values (y-axis) were
compared with the expected P values (x-axis) under the
null hypothesis, with the values being plotted as –log10(P).
BMI, body mass index.  represents the genomic inflation
factor.
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Table 1. Longitudinal characteristics of 6,022 subjects in the discovery cohort
Characteristic Control Obesity Control MetS
Subjects, n 4,220* 1,802* 1,848* 1,576*
Sex, men/women, % 51.3/48.7 53.3/46.7 43.9/56.1 63.4/36.6
Age, yr 52.3 	 0.09 (20,461) 53.0	 0.13 (8,059) 48.8	 0.11 (10,310) 56.3	 0.13 (6,643)
Height, cm 162.1 	 0.06 (19,891) 163.6	 0.11 (8,021) 162.0	 0.09 (10,118) 163.4	 0.12 (6,518)
Weight, kg 56.5 	 0.06 (19,889) 72.3	 0.13 (8,021) 57.1	 0.11 (10,118) 68.7	 0.16 (6,518)
Waist circumference, cm 76.9	 0.06 (15,055) 89.9	 0.10 (6,292) 75.7	 0.09 (7,487) 88.4	 0.12 (5,457)
Body mass index, kg/m2 21.4 	 0.01 (19,889) 26.9	 0.03 (8,021) 21.6	 0.03 (10,118) 25.6	 0.04 (6,518)
Smoking, % 35.7 (20,461) 45.2 (8,059) 33.2 (10,310) 45.8 (6,643)
Hypertension, % 27.3 (20,461) 50.3 (8,059) 15.2 (10,310) 67.3 (6,643)
Systolic blood pressure, mmHg 118.0	 0.11 (19,879) 127.2	 0.18 (8,021) 113.6	 0.14 (10,118) 131.1	 0.20 (6,516)
Diastolic blood pressure, mmHg 72.8	 0.08 (19,879) 79.4	 0.13 (8,021) 70.0	 0.11 (10,118) 81.8	 0.15 (6,516)
Type 2 diabetes mellitus, % 9.3 (20,461) 20.0 (8,059) 5.2 (10,310) 27.1 (6,643)
Fasting plasma glucose, mmol/l 5.51	 0.008 (20,049) 5.92	 0.014 (8,020) 5.29	 0.008 (10,156) 6.22	 0.018 (6,619)
Blood hemoglobin A1c, % 5.64 	 0.005 (15,166) 5.89	 0.010 (5,841) 5.52	 0.005 (7,419) 6.04	 0.012 (4,940)
Dyslipidemia, % 50.4 (20,461) 78.3 (8,059) 42.4 (10,310) 93.4 (6,643)
Serum triglycerides, mmol/l 1.14	 0.006 (20,014) 1.57	 0.012 (8,015) 0.98	 0.005 (10,143) 1.92	 0.015 (6,614)
Serum HDL-cholesterol, mmol/l 1.68	 0.003 (19,987) 1.42	 0.004 (8,007) 1.73	 0.004 (10,125) 1.35	 0.004 (6,604)
Serum LDL-cholesterol, mmol/l 3.11	 0.006 (19,146) 3.37	 0.009 (7,676) 3.08	 0.008 (9,680) 3.36	 0.011 (6,334)
Chronic kidney disease, % 10.5 (20,461) 12.6 (8,059) 6.9 (10,310) 16.7 (6,643)
Serum creatinine, 
mol/l 71.5	 0.81 (20,461) 70.9	 0.55 (7,449) 75.2	 1.14 (9,200) 81.2	 1.38 (6,197)
eGFR, ml min1 1.731 m2 78.8 	 0.14 (18,310) 78.0	 0.18 (7,449) 80.8	 0.18 (9,200) 76.0	 0.23 (6,197)
Hyperuricemia, % 15.0 (20,461) 24.7 (8,059) 12.5 (10,310) 28.2 (6,643)
Serum uric acid, 
mol/l 318.2 	 0.64 (17,934) 356.1	 0.99 (7,323) 308.7	 0.89 (8,954) 361.6	 1.10 (6,117)
Quantitative data are means	 SE. Values in parentheses are the numbers of measurements taken. MetS, metabolic syndrome; HDL, high density lipoprotein;
LDL, low density lipoprotein; eGFR, estimated glomerular filtration rate. *The numbers are based on medical examination data in the final visit for each subject.
Table 2. Significant SNPs identified by the GEE model for obesity, MetS, and BMI with adjustments for age and sex in
6,022 discovery cohort
Traits Model RefSNP ID Location Allele Gene Mutation Estimate Wald P Value MAF FDR Approxdf
MetS dominant rs2075290 11: 116,782,580 T¡C ZPR1 silent 0.35 22.7 1.9  106 0.247 0.0070 119.4
rs2266788 11: 116,789,970 T¡C APOA5 silent 0.35 22.9 1.7  106 0.241 0.0066 114.8
additive rs2305830 11: 117,395,596 C¡G CEP164 missense: T991S/T988S 0.28 24.2 8.4  107 0.282 0.0033 27.0
rs4141253 12: 112,887,824 G¡A RPH3A synonymous: F484F/F488F 0.25 23.1 1.6  106 0.475 0.0055 105.7
recessive rs1052067 1: 156,236,330 G¡A PMF1 silent, missense: M68I 0.70 20.2 7.1  106 0.239 0.0036 14.1
rs2305830 11: 117,395,596 C¡G CEP164 missense: T991S/T988S 0.57 20.1 7.2  106 0.282 0.0036 27.0
BMI, all dominant rs1134767 1: 61,990,342 G¡A PATJ missense: R1282H 0.37 17.1 3.6  105 0.426 0.0054 271.3
rs633715 1: 177,883,445 T¡C 0.38 19.1 1.3  105 0.213 0.0021 167.1
rs543874 1: 177,920,345 A¡G 0.39 20.1 7.3  106 0.211 0.0012 166.4
additive rs633715 1: 177,883,445 T¡C 0.30 17.3 3.2  105 0.213 0.0048 151.9
rs543874 1: 177,920,345 A¡G 0.31 18.3 1.9  105 0.211 0.0030 151.3
rs41532447 4: 19,914,333 G¡A LOC105374511 0.24 15.8 7.0  105 0.426 0.0099 269.6
rs2767434 10: 132,808,904 G¡A CFAP46 synonymous: R2555R 0.28 19.1 1.2  105 0.279 0.0019 207.8
rs2254419 10: 132,810,455 G¡A CFAP46 missense: G2540S 0.28 18.3 1.9  105 0.267 0.0030 195.8
rs1421085 16: 53,767,042 T¡C FTO silent 0.33 18.5 1.7  105 0.177 0.0027 102.7
rs1558902 16: 53,769,662 T¡A FTO silent 0.33 18.2 1.9  105 0.177 0.0030 102.7
rs1121980 16: 53,775,335 G¡A FTO silent 0.29 15.8 7.0  105 0.213 0.0099 138.9
rs17817449 16: 53,779,455 T¡G FTO silent 0.34 19.4 1.1  105 0.177 0.0018 101.7
rs8050136 16: 53,782,363 C¡A FTO silent 0.33 18.4 1.8  105 0.178 0.0028 102.6
rs9939609 16: 53,786,615 T¡A FTO silent 0.33 18.1 2.1  105 0.180 0.0033 105.8
BMI, male* dominant rs2222328 3: 159,541,502 A¡G SCHIP1 silent 0.51 20.7 5.3  106 0.321 0.0009 276.8
rs7656604 4: 71,681,719 G¡A 0.65 16.6 4.7  105 0.082 0.0069 28.9
additive rs2222328 3: 159,541,502 A¡G SCHIP1 silent 0.34 18.4 1.8  105 0.321 0.0028 275.6
rs7656604 4: 71,681,719 G¡A 0.61 17.9 2.4  105 0.082 0.0037 27.5
recessive rs9491140 6: 124,370,091 C¡T NKAIN2 silent 0.94 18.3 1.9  105 0.237 0.0030 24.2
rs145848316 7: 152,185,587 C¡A KMT2C missense: A1685S/A1702S 1.07 16.6 4.5  105 0.178 0.0067 10.9
BMI, female* dominant rs11210490 1: 74,631,742 G¡C ERICH3 missense: P262A/P264A 0.61 16.9 4.0  105 0.091 0.0062 28.5
additive rs11210490 1: 74,631,742 G¡C ERICH3 missense: P262A/P264A 0.57 17.7 2.6  105 0.091 0.0042 27.3
rs6795429 3: 73,918,459 A¡G 0.37 16.7 4.4  105 0.419 0.0068 268.8
recessive rs10274730 7: 15,196,767 T¡C AGMO 0.81 18.5 1.7  105 0.416 0.0026 138.1
rs7863248 9: 85,693,212 T¡C AGTPBP1 silent 0.66 16.8 4.2  105 0.440 0.0060 165.7
rs4792739 17: 16,419,362 T¡C TRPV2 silent 1.24 22.0 2.8  106 0.208 0.0005 17.4
Column descriptions: Model, dominant model, AA vs. AB  BB (A, major allele; B, minor allele); recessive model (AA  AB vs. BB); additive model
(AA  AB  BB); Location, location in NCBI build GRCh38.p10; Estimate, estimate of coefficient; Wald, Wald statistics; FDR, false discovery rate (FDR 
0.01); Approxdf, a scale of small effective sample size (approxdf 10). SNP, single nucleotide polymorphism; BMI, body mass index; MetS, metabolic
syndrome; MAF, minor allele frequency. *Generalized estimating equation (GEE) model was performed with adjustment for age only.
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The GEE test with adjustment for age showed that BMI of
3,348 female subjects was significantly related to five SNPs
(rs11210490 of ERICH3, rs6795429 at 3q13, rs10274730 of
AGMO, rs7863248 of AGTPBP1, and rs4792739 of TRPV2) in
the three inheritance models (Table 2). All of these SNPs have
not been previously reported to be associated with BMI. The
mean BMI values of subjects with major alleles of these
SNPs, except for rs10274730 in AGMO, were significantly
greater than those of subjects with the minor alleles
(FDR  0.0005– 0.0068, Table 2 and Supplemental Table
S1). As with rs7656604 at 4q13.3, frequencies of the major
allele of rs4792739 in TRPV2 were much higher in non-
African populations than those in African populations (Sup-
plemental Table S2).
We have examined interaction with sex for each candidate
SNP showing significant association with BMI in the sex-
stratified analysis with Fisher’s exact test (Table 4). There was
no significant association between them (P  0.05), with the
exception of rs4792739 in TRPV2. The genotype frequencies
in the SNP of TRPV2 were significantly different between
males and females in all inheritance models (P  0.022–
0.030).
Replication studies for candidate SNPs related to obesity or
MetS. We examined the association of 16 candidate SNPs
identified in our longitudinal exome-wide association studies
of the prevalence of obesity and MetS or BMI, by the use of
cross-sectional data for the related phenotypes in 7,285 Japa-
nese individuals of the replication cohort (Supplemental TableTa
bl
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Table 4. Fisher’s exact test for sex and candidate SNPs
showing significant association with BMI in the sex-stratified
analysis in the discovery cohort
RefSNP ID Location Gene Model P Value
rs11210490 1: 74,631,742 ERICH3 additive 0.574
dominant 0.626
recessive 0.347
rs6795429 3: 73,918,459 additive 0.183
dominant 0.067
recessive 0.656
rs2222328 3: 159,541,502 SCHIP1 additive 0.723
dominant 0.958
recessive 0.455
rs7656604 4: 71,681,719 additive 0.472
dominant 0.480
recessive 0.462
rs9491140 6: 124,370,091 NKAIN2 additive 0.537
dominant 0.344
recessive 0.433
rs10274730 7: 15,196,767 AGMO additive 0.845
dominant 0.785
recessive 0.566
rs145848316 7: 152,185,587 KMT2C additive 0.891
dominant 0.845
recessive 0.760
rs7863248 9: 85,693,212 AGTPBP1 additive 0.632
dominant 0.738
recessive 0.352
rs4792739 17: 16,419,362 TRPV2 additive 0.022
dominant 0.026
recessive 0.030
Column descriptions: Location, location in NCBI build GRCh38.p10;
Model, additive model, AA  AB  BB (A, major allele; B, minor allele);
dominant model (AA vs. AB  BB); recessive model (AA  AB vs. BB.
Boldface, statistically significant P values.
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S3). In the replication study, the Fisher’s exact test or linear
regression analysis showed association of rs9491140 in
NKAIN2 with BMI in men (P  0.036), rs145848316 in
KMT2C with BMI in men (P  0.030) and women (P 
0.010–0.019), and rs7863248 in AGTPBP1 with BMI in all
individuals (P  0.003–0.026) and men (P  0.020–0.041)
and with the prevalence of obesity (P  0.016–0.049).
The replication study showed no association between the
prevalence of MetS and the 16 candidate SNPs. The rs2305830
of CEP164 was associated with BMI in all individuals (P 
0.016–0.047) and in men (P  0.017–0.029) and with the
prevalence of obesity (P  0.022–0.036), although this SNP
was associated with MetS in the longitudinal exome-wide
association study. Given that an increase in BMI may be
related to the development of MetS, rs2305830 might be a
candidate susceptibility locus for MetS.
DISCUSSION
We identified a total of 26 SNPs that were related to BMI or
the prevalence of MetS in the longitudinal exome-wide asso-
ciation studies. Among these SNPs, 16 have not been previ-
ously implicated as determinants of BMI or MetS. If we
applied Bonferroni’s correction [a P value of 2.03  106
(0.05/24,579 SNPs)], the association of two SNPs (rs2305830
of CEP164 and rs4141253 of RPH3A) with the prevalence of
MetS was significant (P  8.4  107 to 1.9  106). How-
ever, the association of these SNPs was not observed in the
replication study. In the longitudinal exome-wide association
studies for the discovery cohort, rs7863248 of AGTPBP1,
rs9491140 of NKAIN2, and rs145848316 of KMT2C were
significantly (FDR 0.01) associated with BMI in women or
men. The association of these SNPs was also detected in
cross-sectional data for BMI of 7,285 Japanese subjects in the
replication study. The SNP rs7863248 in AGTPBP1 was also
associated with the prevalence of obesity in the replication
study. We have thus identified the three SNPs as susceptibility
loci for BMI. Function and related phenotypes of these genes
are shown in Table 5.
We compared phenotypes showing the association with the
three identified SNPs between the discovery and replication
cohorts. rs9491140 of NKAIN2 was commonly associated with
BMI in men in both cohorts. rs145848316 of KMT2C showed
association with BMI in men and BMI in men and women in
the discovery and replication cohorts, respectively. rs7863248
of AGTPBP1 was significantly associated with BMI in women
in the discovery cohort, whereas this SNP was related to BMI
in men and all individuals and the prevalence of obesity in the
replication cohort.
rs145848316 (C¡A, A1685S) of the lysine methyltrans-
ferase 2C gene (KMT2C) was associated with BMI in men in
the discovery and replication cohorts. The KMT2C protein is
involved in histone methyltransferase activity and transcrip-
tional coactivation. A comparison of gene expression patterns
between patients with schizophrenia and controls showed that
the expression level of KMT2C in postmortem brain tissues
was significantly upregulated in schizophrenia patients (34). A
maternal obesity or elevated maternal BMI may increase the risk
for schizophrenia in offspring (30). Shared pathophysiological
pathways linking obesity to neuropsychological impairments may
be attributable to cognitive dysfunction (5, 19). The amino acid
alteration in KMT2C may thus be related to the increased BMI,
although the functional relevance of rs145848316 to increased
BMI remains unknown.
In the discovery cohort, rs7863248 (T¡C in intron) of the
ATP/GTP binding protein 1 gene (AGTPBP1) was signifi-
cantly associated with BMI in women. The AGTPBP1 protein
is a zinc carboxypeptidase that catalyzes deglutamylation of
polyglutamylated proteins. Neurodegeneration in Purkinje cell
degeneration (pcd) mice may be caused by microtubule hyper-
glutamylation through loss of AGTPBP1 protein function (31).
Neurodegenerative disorders may be linked to obesity through
the shared pathophysiological mechanisms (5, 19). We have
shown that rs7863248 (T¡C) of AGTPBP1 was associated
with the increased BMI, although the underlying mechanism of
this association remains unclear.
The SNP rs9491140 (C¡T in intron) of the sodium/potas-
sium transporting ATPase interacting 2 gene (NKAIN2) was
commonly associated with BMI in men in the two cohorts
examined. NKAIN2 is a transmembrane protein that interacts
with the beta subunit of a sodium/potassium transporting
ATPase. Previous studies have shown that NKAIN2 may be
related to neurological phenotypes such as major depression (9,
10). Given that pathophysiological mechanisms are shared
between some neurodegenerative disorders and obesity,
rs9491140 of NKAIN2 may be associated with BMI, although
the functional relevance remain unclear.
There are certain limitations to note given our study design.
First, the longitudinal exome-wide association study and cross-
sectional replication study were conducted in a local Japanese
population. Therefore, replication studies in other ethnic
groups are required to verify the association of identified SNPs
with BMI. Second, the molecular mechanisms of the three
SNPs identified in the present study to the pathogenesis of
increased BMI remains unclear. Further functional analysis is
required to clarify the results of this study. Third, genetic
Table 5. Function and related diseases of proteins with candidate SNPs identified in the present study
Protein Name Symbol Function Association
Main Expression Tissues
or Organs
ATP/GTP binding protein 1 AGTPBP1 catalyzing deglutamylation of polyglutamylated
proteins
neurodegeneration (31)* ubiquitous expression
Lysine methyltransferase 2C KMT2C histone methyltransferase activity and
transcriptional coactivation
schizophrenia (34)* ubiquitous expression
Sodium/potassium transporting
ATPase interacting 2
NKAIN2 interactions with the beta subunit of a sodium/
potassium transporting ATPase
genetic diseases with neurological
phenotype such as major
depression (9, 10)*
brain
The expression sites are according to The Human Protein Atlas (http://www.proteinatlas.org/). *The neuropsychiatric disorders can increase a risk for obesity
(5, 19, 30).
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variants on sex chromosomes were not examined in our lon-
gitudinal exome-wide association studies.
In conclusion, our results showed that three SNPs (rs7863248
of AGTPBP1, rs9491140 of NKAIN2, and rs145848316 of
KMT2C) were significantly associated with BMI in the Japanese
population. Our study has implications for uncovering novel
susceptibility loci for increased BMI.
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